You have 9 free searches left this month | for more free features.

Remission maintenance

Showing 1 - 25 of 9,078

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

Recruiting
  • ANCA-associated Vasculitis
  • Maintenance Therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

Recruiting
  • Giant Cell Arteritis
  • Bonn, Germany
    Medical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022

Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)

Not yet recruiting
  • Autoimmune Diseases
  • placebo
  • mycophenolate mofetil
  • Beijing, China
    Peking Union Medical College Hospital
Jul 26, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

Not yet recruiting
  • Non-radiographic Axial Spondyloarthritis
  • (no location specified)
Nov 16, 2022

Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Discontinuation of maintenance treatment
  • Cork, Ireland
    Cork University Hospital
May 10, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

Not yet recruiting
  • Progression Free Survival
  • +2 more
  • Ixazomib DX/Lenalidomide DX
  • (no location specified)
Jul 27, 2022

Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Crohn Disease Trial in Liège (EXL01, Placebo, SoC corticosteroid - Induction Period)

Not yet recruiting
  • Crohn Disease
  • Liège, Belgium
    CHU de Liege
Sep 13, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Springfield (Omega Nutrition cold-milled

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Omega Nutrition cold-milled flaxseeds
  • Springfield, Illinois
    Southern Illinois University School of Medicine
Mar 30, 2022

IgG4-related Disease Trial (Sirolimus)

Not yet recruiting
  • IgG4-related Disease
  • (no location specified)
Feb 25, 2023

Bipolar Depression, Suicidal Ideation Trial in United States (NRX-101, Lurasidone HCl)

Active, not recruiting
  • Bipolar Depression
  • Suicidal Ideation
  • Birmingham, Alabama
  • +3 more
Aug 9, 2022

Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Miami, Florida
  • +2 more
Apr 21, 2022

Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)

Recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Paris, France
    Hôpital Cochin
Feb 9, 2022

Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

Completed
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 18, 2022

Maintenance of Remission With Pentasa as Ulcerative Colitis

Completed
  • Ulcerative Colitis
  • Zutphen, Netherlands
    Gelre Ziekenhuizen (there may be other sites in this country)
May 16, 2022

MDD, Recurrent, in Remission Trial (Negative ion therapy, Light therapy)

Not yet recruiting
  • Major Depressive Disorder, Recurrent, in Remission
  • Negative ion therapy
  • Light therapy
  • (no location specified)
Jul 19, 2022

Crohn's Disease Trial in Worldwide (Modified Exclusive Enteral Nutrition, Crohn's Disease Exclusion Diet, Partial Enteral

Completed
  • Crohn's Disease
  • Modified Exclusive Enteral Nutrition
  • +3 more
  • Edmonton, Canada
  • +6 more
May 29, 2022

Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)

Recruiting
  • Idiopathic Pulmonary Hemosiderosis
  • Leflunomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023

Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

Recruiting
  • Acute Myeloid Leukemia
  • Decitabine and Cedazuridine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • Rituximab, Methotrexate, Temozolomide
  • Paris, France
    Groupe Hospitalier Pitie Salpetriere
Feb 10, 2022

Ulcerative Colitis Trial (Intravenous (IV) infusions)

Not yet recruiting
  • Ulcerative Colitis
  • Intravenous (IV) infusions
  • (no location specified)
Mar 14, 2023

Steroid-Dependent Nephrotic Syndrome Trial in Kolkata (Rituximab, Mycophenolate Mofetil)

Active, not recruiting
  • Steroid-Dependent Nephrotic Syndrome
  • Kolkata, West Bengal, India
    Nilratan Sircar Medical College and Hospital
Apr 6, 2022